血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura):治療薬市場2019(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2016427)
◆英語タイトル:Thrombotic Thrombocytopenic Purpura-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2016427
◆発行日:2020年07月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,000 ⇒換算¥214,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥642,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura):治療薬市場2019(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)]についてメールでお問い合わせはこちら
※当調査レポートでは、血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)治療薬の世界市場動向について調査・分析し、以下の構成でお届けいたします。

・血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura):適応症(疾患)の概要
・市販医薬品の状況
・世界のAPI(医薬品原薬)メーカー分析
・地域別APIメーカー状況(アメリカ、ヨーロッパ、中国など)
・血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)のフェーズ3治験薬の状況
・血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)治療薬の市場規模(販売予測)
・血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)の市販医薬品分析
 (医薬品名、説明、APIメーカー、承認状況、特許など)
・血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)のフェーズ3治験薬分析
・開発中止中の血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)治療薬剤
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s Report, “Thrombotic Thrombocytopenic Purpura-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Thrombotic Thrombocytopenic Purpura Report is to understand the market and pipeline status of the drugs around the Thrombotic Thrombocytopenic Purpura to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2021. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Thrombotic Thrombocytopenic Purpura. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market and Phase III therapeutics scenario for Thrombotic Thrombocytopenic Purpura.
• A review of the marketed products under prescription for Thrombotic Thrombocytopenic Purpura, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Thrombotic Thrombocytopenic Purpura with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Thrombotic Thrombocytopenic Purpura drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Thrombotic Thrombocytopenic Purpura drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Thrombotic Thrombocytopenic Purpura drugs.
• Coverage of Thrombotic Thrombocytopenic Purpura Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2021.


*** レポート目次(コンテンツ)***

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2021
6. Marketed Drugs for Thrombotic Thrombocytopenic Purpura
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Thrombotic Thrombocytopenic Purpura
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Thrombotic Thrombocytopenic Purpura
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, Marketed Drugs by Application Type, 2019
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, Marketed Drugs by Marketing Status, 2019
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, (Year), 2019
• Thrombotic Thrombocytopenic Purpura Marketed Drugs, API Manufacturers by US DMF Status, 2019
• Thrombotic Thrombocytopenic Purpura Marketed Drugs, US DMF Status Drug Specific (Number), 2019
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, Europe by Country, 2019
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, India by State, 2019
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, China by Province, 2019
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers by Geography 2019
• Thrombotic Thrombocytopenic Purpura Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2019
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, Global Sales-2021 (in million USD)
• API Manufacturers for Drug, 2019
• Phase III Drugs for Thrombotic Thrombocytopenic Purpura, 2019
• Discontinued Drugs for Thrombotic Thrombocytopenic Purpura, 2019


List of Figures
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, Marketed Drugs by Application Type (%), 2019
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2019
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, (Year), 2019
• Thrombotic Thrombocytopenic Purpura Marketed Drugs, API Manufacturers by US DMF Status (%), 2019
• Thrombotic Thrombocytopenic Purpura Marketed Drugs, US DMF Status Drug Specific (Number), 2019
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, Europe by Country, 2019
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, India by State, 2019
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, China by Province, 2019
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers by Geography 2019
• Thrombotic Thrombocytopenic Purpura Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2019
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, Global Sales 2021 (in million USD)
• Drug, Patent/Exclusivity Expiry (Year), 2019


*** レポートのキーワード ***

血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)、薬剤、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品(市販薬)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • ホットランナーの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)
    This report studies the Hot Runner market, Hot runner system is an assembly of heated components—hot halves, nozzles and gates and—that inject plastic into the cavities of an injection mold. The system usually includes a heated manifold and a number of heated nozzles. The manifold distributes the pl …
  • VAV (可変風量) ボックスの世界市場予測(~2024年)
    “The growth in VAV BOX demand is increasing due to the growing construction industry, especially commercial and industrial construction in developing countries due to rapid economic development.”The VAV BOX market size is estimated to be USD 4.7 billion in 2019 and is projected to reach USD 6.4 bill …
  • 滑りベアリングの世界市場予測(~2027年)
    Increasing demand for reliable and cost-effective sliding bearings and the rising capital expenditure for railway infrastructure are expected to fuel the demand for the sliding bearing marketThe sliding bearing market is projected to reach USD 1,531 million by 2027 from USD 934 million in 2019, at a …
  • 自己浄化水の世界市場
    In this report, the global Self-Cleaning Water market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, reven …
  • 肺炎球菌性髄膜炎(Pneumococcal Meningitis):治療薬開発パイプライン動向2019
    SUMMARY DelveInsight’s, “ Pneumococcal Meningitis-Pipeline Insights, 2019”, report provides in depth insights on the pipeline drugs and their development activities around the Pneumococcal Meningitis. The DelveInsight’sReport covers the product profiles in various stages of development including Dis …
  • RFIDリーダーの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)
    An RFID reader, also known as an interrogator, is a device that provides the connection between the tag data and the enterprise system software that needs the information. The reader communicates with tags that are within its field of operation, performing any number of tasks including simple contin …
  • プラスチックモップの世界及び中国市場 2018年
    The 'Global and Chinese Plastic Mop Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Plastic Mop industry with a focus on the Chinese market. The report provides key statistics on the market status of the Plastic Mop manufacturers an …
  • スマートガスメーターの世界市場:インサイト、市場機会、市場シェア、市場予測
    The smart gas meter market is anticipated to grow from $1.59 billion in 2016 to $2.27 billion by 2022, with a CAGR of 8.53% for the forecasted year 2016 to 2022. Some key driving factors are government policies & directives, ability to precise billings & improved customer service and better performa …
  • テルルの世界市場:用途別、地域別
    Global tellurium market 2020-2024 Technavio has been monitoring the global tellurium market and it is poised to grow by USD 60.03 MT during 2020-2024, progressing at a CAGR of 3% during the forecast period. Our reports on global tellurium market provides a holistic analysis, market size and forecast …
  • 世界及び中国の自動車用DVR市場2017
    The 'Global and Chinese Car DVR Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Car DVR industry with a focus on the Chinese market. The report provides key statistics on the market status of the Car DVR manufacturers and is a valua …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2016427 )"血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura):治療薬市場2019(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)" (英文:Thrombotic Thrombocytopenic Purpura-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。